These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 15546076
1. Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics. Gillespie SH. Clin Infect Dis; 2004 Nov 15; 39(10):1431-2. PubMed ID: 15546076 [No Abstract] [Full Text] [Related]
2. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro]. Golyshevskaia VI, Selishcheva AA, Martynova LP, Lepekha LN, Kalashnikova TM, Kornilova ZKh, Erokhin VV, Rozenberg OA. Probl Tuberk Bolezn Legk; 2006 Nov 15; (8):61-4. PubMed ID: 17002062 [Abstract] [Full Text] [Related]
3. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Donald PR, Sirgel FA, Venter A, Parkin DP, Seifart HI, van de Wal BW, Werely C, van Helden PD, Maritz JS. Clin Infect Dis; 2004 Nov 15; 39(10):1425-30. PubMed ID: 15546075 [Abstract] [Full Text] [Related]
4. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. Gumbo T, Louie A, Liu W, Ambrose PG, Bhavnani SM, Brown D, Drusano GL. J Infect Dis; 2007 Jan 15; 195(2):194-201. PubMed ID: 17191164 [Abstract] [Full Text] [Related]
11. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R, Sharma S, Khuller GK. Int J Antimicrob Agents; 2004 Apr 15; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
12. [Reasons for drug-resistant tuberculosis emergence]. Tu DH. Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 15; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
13. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis]. Novozhilova IA. Probl Tuberk Bolezn Legk; 2004 Jun 15; (4):29-31. PubMed ID: 15171041 [No Abstract] [Full Text] [Related]
14. Evaluation of an intracellular pharmacokinetic in vitro infection model as a tool to assess tuberculosis therapy. Cappelletty DM. Int J Antimicrob Agents; 2007 Feb 15; 29(2):212-6. PubMed ID: 17204402 [Abstract] [Full Text] [Related]
16. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis. Jayaram R, Shandil RK, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Kantharaj E, Balasubramanian V. Antimicrob Agents Chemother; 2004 Aug 15; 48(8):2951-7. PubMed ID: 15273105 [Abstract] [Full Text] [Related]
17. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. Ahmad Z, Klinkenberg LG, Pinn ML, Fraig MM, Peloquin CA, Bishai WR, Nuermberger EL, Grosset JH, Karakousis PC. J Infect Dis; 2009 Oct 01; 200(7):1136-43. PubMed ID: 19686043 [Abstract] [Full Text] [Related]